Back to Agenda
DIA Clinical Safety and Pharmacovigilance Community Round Table Discussion: Risk Management - New Directions
Session Chair(s)
Catherine Baldridge, MSc
Head of Safety
Fusion Pharmaceuticals, United States
Seating is limited.
Join DIA CSP Community round table discussion tied to session # 251 Risk Management: New Directions (Tuesday, June 26th)
To include special guests from the session: Helen Kathryn Edelberg and Mark Perrott.
Have an account?